ProCE Banner Activity

BCMA-Targeted Bispecific T-Cell Engagers and Bispecific Monoclonal Antibodies in R/R MM

Slideset Download
Download this slideset based on the content from a live stream CCO webinar from Suzanne Lentzsch, MD, PhD, on the latest data on BCMA x CD3 bispecific molecules for patients with relapsed/refractory multiple myeloma.

Released: September 10, 2021

Expiration: September 09, 2022

Share

Faculty

Suzanne Lentzsch

Suzanne Lentzsch, MD, PhD

Director, Multiple Myeloma and Amyloidosis Program
Associate Professor of Medicine
Division of Hematology/Oncology
Columbia University Medical Center
New York, New York

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

GlaxoSmithKline

Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC

Faculty Disclosure

Primary Author

Suzanne Lentzsch, MD, PhD

Director, Multiple Myeloma and Amyloidosis Program
Associate Professor of Medicine
Division of Hematology/Oncology
Columbia University Medical Center
New York, New York